Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QDPR | P09417 | 2/20 | 0.43 |
| ▸ | TRPC6 | Q9Y210 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 4/20 | 0.41 |
| ▸ | DRD3 | P35462 | 4/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
| ▸ | HTR1B | P28222 | 1/20 | 0.41 |
| ▸ | HTR1F | P30939 | 1/20 | 0.41 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1392852 | 0.94 | QDPR (0.47) | QDPRTRPC6DRD2DRD3DRD4 | |
| SCHEMBL4893089 | 0.88 | SLC6A2 (0.48) | DRD2DRD3DRD4 | |
| SCHEMBL23707252 | 0.84 | DRD2 (0.46) | QDPRTRPC6DRD2DRD3DRD4 | |
| SCHEMBL22583349 | 0.82 | KDM4E (0.51) | TRPC6DRD2DRD3TNKSNOS3 | |
| SCHEMBL15718047 | 0.82 | KDM4E (0.47) | TRPC6DRD2DRD3DRD4TNKS | |
| SCHEMBL15924745 | 0.80 | KDM4E (0.54) | TRPC6DRD2DRD3TNKSNOS3 | |
| SCHEMBL1355472 | 0.78 | TNKS (0.47) | TRPC6DRD2DRD3DRD4TNKS | |
| SCHEMBL27676281 | 0.77 | TRPC6 (0.48) | QDPRTRPC6TNKS | |
| SCHEMBL25716511 | 0.77 | DRD2 (0.47) | TRPC6DRD2DRD3DRD4TNKS | |
| SCHEMBL18823274 | 0.77 | DRD2 (0.45) | TRPC6DRD2DRD3DRD4TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3988545-A1 | METHODS FOR PREPARING CDK4/6 INHIBITOR AND SALT AND INTERMEDIATE THEREOF | Gan & Lee Pharmaceuticals Co., Ltd. (CN) | 2022-04-27 | — | — | EP | disclosed |